<DOC>
	<DOCNO>NCT02695810</DOCNO>
	<brief_summary>The overall objective compare short-term ( 3 month ) effectiveness three glucose-lowering intervention ( dapagliflozin , metformin physical activity ) glucose variability , body composition , cardiometabolic risk factor overweight obese individual pre-diabetes ( HbA1c 5.7-6.4 % / 39-47 mmol/mol ) .</brief_summary>
	<brief_title>The PRE-D Trial : Effect Dapagliflozin , Metformin Physical Activity Pre-diabetes</brief_title>
	<detailed_description>Different medical therapy lifestyle modification prevention type 2 diabetes yet compare head-to-head individual pre-diabetes . This research project compare different glucose-lowering intervention overweight obese individual HbA1c level pre-diabetic range .</detailed_description>
	<mesh_term>Prediabetic State</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>HbA1c : ≥5.7 % ( 39 mmol/mol ) ≤6.4 % ( 47 mmol/mol ) Age : ≥30 ≤70 year age BMI ≥25 kg/m2 Uncontrolled medical issue include limited cardiovascular pulmonary , rheumatologic , hematologic , oncologic , infectious , gastrointestinal psychiatric disease ; diabetes endocrine disease ; immunosuppression ; Current treatment hormone affect glucose metabolism ; Current treatment loop diuretic thiazolidinediones ; Current treatment beta blocker peroral steroid ; Bariatric surgery within past 2 year ; Impaired renal function define estimate GFR &lt; 60 ml/min/1.73m2 ; Neurogenic bladder disorder ; Alcohol/drug abuse treatment disulfiram ( Antabus ) time inclusion ; Pregnant lactate woman ; Fertile woman use birth control agent include oral contraceptive , gestagen injection , subdermal implant , hormonal vaginal ring , transdermal application , intrauterine device ; Allergic one medication use study ; Concomitant participation intervention study ; Unable understand inform consent study procedure .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>